Completed NA INTERVENTIONAL 2-arm NCT05794113

Comparing the Use of a Mobile App for Surveillance of Adverse Events Following Influenza Immunization to a Web-Based Platform

Comparing the Use of a Mobile App for Surveillance of Adverse Events Following Influenza Immunization to a Web-Based Platform: a Randomized Controlled Trial

Sponsor: The Ottawa Hospital

Conditions Adverse Event Following Immunisation Immunization Mobile Apps

Interventions Mobile app - CanImmunize Web based notification

Updated 3 times since 2023 Last updated: Mar 28, 2023 Started: Oct 1, 2020 Primary completion: Oct 1, 2021 Completion: Oct 1, 2021

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Adverse Event Following Immunisation and Immunization and is currently completed. The Ottawa Hospital leads this study, which shows 3 recorded versions since 2020 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

3 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
May 2023 — Jul 2024 [monthly]

Completed NA

First recorded

Oct 2020

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

The Ottawa Hospital

Data source: The Ottawa Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Ottawa, Canada